research use only

D-Mannose

Cat.No.S5763

D-mannose is a naturally occurring simple sugar that may help your body cleanse the urinary tract and maintain a healthy bladder lining.
D-Mannose Chemical Structure

Chemical Structure

Molecular Weight: 180.16

Quality Control

Batch: S576301 DMSO]36 mg/mL]false]]]false]]]false Purity: 98%
98

Chemical Information, Storage & Stability

Molecular Weight 180.16 Formula

C6H12O6

Storage (From the date of receipt) 3 years -20°C powder
CAS No. 3458-28-4 -- Storage of Stock Solutions

Synonyms N/A Smiles OCC1OC(O)C(O)C(O)C1O

Solubility

In vitro
Batch:

DMSO : 36 mg/mL (199.82 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Molarity Calculator

Mass Concentration Volume Molecular Weight

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg g μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO % % Tween 80 % ddH2O
%DMSO %

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Mechanism of Action

Clinical Trial Information

(data from https://clinicaltrials.gov, updated on 2024-05-22)

NCT Number Recruitment Conditions Sponsor/Collaborators Start Date Phases
NCT06360055 Recruiting
Health
Peking University Third Hospital
April 1 2024 Not Applicable
NCT05186285 Unknown status
Healthy
Keymed Biosciences Co.Ltd
December 11 2021 Phase 1
NCT04505982 Unknown status
Rheumatoid Polyarthritis
BADOT Valerie|Brugmann University Hospital
July 14 2020 --
NCT03395288 Terminated
Urinary Tract Infections
Washington University School of Medicine
March 22 2018 Phase 2|Phase 3
NCT04888260 Completed
Coronary Artery Disease|Hyperlipidemias
Kafkas University
January 10 2018 --

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.